TomoTherapy(R) Cancer Treatment Technology Debuts In Switzerland

TomoTherapy Incorporated (NASDAQ: TTPY) announced that the University Hospital of Lausanne (CHUV) has begun treating patients with the TomoTherapy(R) Hi-Art(R) treatment system, the first to be installed in Switzerland.

"We are pleased to work with the CHUV to make this new weapon in the fight against cancer available to Swiss patients," said Rik Van den Neste, M.D., director of European sales for TomoTherapy. "By implementing the TomoTherapy platform, the CHUV demonstrates its leadership and commitment to providing access to new strategies for care."

source